Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum -lactamases: a systematic review and meta-analysis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum -lactamases: a systematic review and meta-analysis
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 67, Issue 12, Pages 2793-2803
Publisher
Oxford University Press (OUP)
Online
2012-08-22
DOI
10.1093/jac/dks301
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictors of Mortality in Patients with Bacteremia of Unknown Source Due to Extended Spectrum Beta-Lactamase ProducingEscherichia coli
- (2014) G. Metan et al. JOURNAL OF CHEMOTHERAPY
- Klebsiella ESBL bacteremia-mortality and risk factors
- (2012) Felipe Francisco Tuon et al. Brazilian Journal of Infectious Diseases
- Piperacillin–tazobactam as an initial empirical therapy of bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
- (2012) Cheol-In Kang et al. JOURNAL OF INFECTION
- Bacteremia Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type ST131 and Non-ST131 Clones: Comparison of Demographic Data, Clinical Features, and Mortality
- (2011) Hsing-Chun Chung et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- -Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
- (2011) J. Rodriguez-Bano et al. CLINICAL INFECTIOUS DISEASES
- The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria
- (2011) F. G. De Rosa et al. INFECTION
- Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria
- (2011) Yen-Hsu Chen et al. JOURNAL OF INFECTION
- Factores de riesgo de mortalidad en pacientes con bacteriemia por cepas productoras de betalactamasas de espectro extendido
- (2011) O. Ferrández et al. REVISTA CLINICA ESPANOLA
- Bacteremia Due to Extended-Spectrum- -Lactamase-Producing Enterobacter cloacae: Role of Carbapenem Therapy
- (2010) C.-C. Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Susceptibility of Gram-Negative Pathogens Isolated from Patients with Complicated Intra-Abdominal Infections in the United States, 2007-2008: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)
- (2010) D. J. Hoban et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of Empiric Therapy with a -Lactam Alone or Combined with an Aminoglycoside on Prognosis of Bacteremia Due to Gram-Negative Microorganisms
- (2010) J. A. Martinez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Infections with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae
- (2010) Johann D.D. Pitout DRUGS
- Antimicrobial susceptibility of intra-abdominal Gram-negative bacilli from Europe: SMART Europe 2008
- (2010) S. Hawser et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections
- (2010) Zubair A. Qureshi et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Epidemiology of extended spectrum β-lactamase producing Enterobacter bacteremia in a brazilian hospital
- (2010) Felipe Francisco Tuon et al. Revista da Sociedade Brasileira de Medicina Tropical
- Mortality rate in neonates infected with extended-spectrum β lactamase-producing Klebsiella species and selective empirical use of meropenem
- (2009) S. Velaphi et al. ANNALS OF TROPICAL PAEDIATRICS
- Community‐Onset Bacteremia Due to Extended‐Spectrum β‐Lactamase–ProducingEscherichia coli:Risk Factors and Prognosis
- (2009) Jesús Rodríguez‐Baño et al. CLINICAL INFECTIOUS DISEASES
- Bacteraemia due to extended-spectrum -lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome
- (2009) C. Gudiol et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Extended-spectrum β-lactamase-producing organisms
- (2009) M.E. Falagas et al. JOURNAL OF HOSPITAL INFECTION
- Monte Carlo simulation for evaluation of the efficacy of carbapenems and new quinolones against ESBL-producing Escherichia coli
- (2009) Tatsuya Nakamura et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli
- (2008) Jesús Rodríguez-Baño et al. ARCHIVES OF INTERNAL MEDICINE
- The Difference between Adequate and Appropriate Antimicrobial Treatment
- (2008) I. I. Siempos et al. CLINICAL INFECTIOUS DISEASES
- Other antimicrobials of interest in the era of extended-spectrum β-lactamases: fosfomycin, nitrofurantoin and tigecycline
- (2008) J. Garau CLINICAL MICROBIOLOGY AND INFECTION
- MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates
- (2008) Philip J. Turner DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Predictors of Mortality From Community-Onset Bloodstream Infections Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae
- (2008) Anucha Apisarnthanarak et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
- (2008) Johann DD Pitout et al. LANCET INFECTIOUS DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now